RMH Holdings Limited (HKG:8437)
Hong Kong
· Delayed Price · Currency is HKD 0.1970
+0.0200 (11.30%)
Jun 10, 2025, 1:01 PM HKT
RMH Holdings Revenue
In the year 2024, RMH Holdings had annual revenue of 5.13M SGD with 61.26% growth. RMH Holdings had revenue of 63.50K in the quarter ending December 31, 2024, a decrease of -93.17%.
Revenue
5.13M SGD
Revenue Growth
+61.26%
P/S Ratio
0.45
Revenue / Employee
113.96K SGD
Employees
45
Market Cap
13.12M HKD
Revenue Chart
* This company reports financials in SGD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.13M | 1.95M | 61.26% |
| Dec 31, 2023 | 3.18M | -1.06M | -25.02% |
| Dec 31, 2022 | 4.24M | 4.00M | 1,681.93% |
| Dec 31, 2021 | 238.00K | -8.00M | -97.11% |
| Dec 31, 2020 | 8.24M | 1.01M | 13.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |